Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Published online before print August 30, 2002, 10.1148/radiol.2251011377
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2251011377v1
225/1/104    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gerber, B. L.
Right arrow Articles by Kraitchman, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gerber, B. L.
Right arrow Articles by Kraitchman, D. L.
(Radiology 2002;225:104-112.)
© RSNA, 2002

Experimental Studies

Single-Vessel Coronary Artery Stenosis: Myocardial Perfusion Imaging with Gadomer-17 First-Pass MR Imaging in a Swine Model of Comparison with Gadopentetate Dimeglumine1

Bernhard L. Gerber, MD, PhD, David A. Bluemke, MD, PhD, Bennett B. Chin, MD, Raymond C. Boston, PhD, Alan W. Heldman, MD, João A. C. Lima, MD and Dara L. Kraitchman, VMD, PhD

1 From the Departments of Medicine, Division of Cardiology (B.L.G., A.W.H., J.A.C.L.), and Radiology (D.A.B., B.B.C., D.L.K.), Johns Hopkins Medical Institutions, 601 N Caroline St, Suite 4231, Baltimore, MD 21287-0845; and Department of Veterinary Medicine, University of Pennsylvania, Kennett Square, Pa (R.C.B.). From the 2000 RSNA scientific assembly. Received August 13, 2001; revision requested October 10; final revision received April 2, 2002; accepted April 12. Supported by grants from Schering, Berlin, Germany, and Berlex Laboratories, Wayne, NJ. Address correspondence to D.L.K. (e-mail: dara@mri.jhu.edu).

PURPOSE: To evaluate the ability of Gadomer-17 to depict perfusion defects in a closed-chest swine model of single-vessel coronary artery disease.

MATERIALS AND METHODS: Twelve pigs underwent closed-chest placement of a flow reducer for 70%–90% luminal stenosis in the proximal left anterior coronary artery. Magnetic resonance (MR) perfusion imaging with Gadomer-17 and gadopentetate dimeglumine, microsphere blood flow (MBF) testing, and technetium 99m (99mTc) 2 methoxyisobutylisonitrile (MIBI) single photon emission computed tomography (SPECT) were performed during dipyridamole vasodilation. Comparisons of percentage signal intensity (SI) increase (PSIC) in remote and ischemic myocardium were made with repeated measurements analysis of variance after injection of both tracers.

RESULTS: Perfusion defects and reduced PSIC in the anterior ischemic versus the inferior remote myocardium could be identified after injection of both Gadomer-17 (PSIC, 66% ± 30 [mean ± SD] vs 100% ± 32, respectively; P < .001) and gadopentetate dimeglumine (PSIC, 49% ± 31 vs 81% ± 43, respectively; P < .005). The size of perfusion defect depicted with both tracers was highly correlated with defect size at 99mTc MIBI SPECT (r = 0.69, P < .05 for Gadomer-17 and r = 0.60, P = .05 for gadopentetate dimeglumine) and with areas of reduced MBF (r = 0.70, P < .05 for Gadomer-17 and r = 0.80, P < .05 for gadopentetate dimeglumine). PSIC also correlated with MBF (r = 0.89, P < .001 for Gadomer-17 and r = 0.75, P < .001 for gadopentetate dimeglumine). Gadomer-17 allowed differentiation of ischemic from nonischemic myocardium, as demonstrated by reduced PSIC (PSIC, 48% ± 38 vs 72% ± 31, respectively; P < .001) until 20 minutes after contrast material injection. In contrast, differentiation of ischemic from nonischemic myocardium was possible only until 55 seconds after injection of gadopentetate dimeglumine (PSIC, 36% ± 24 vs 56% ± 27, respectively; P < .005) but not at any time point thereafter.

CONCLUSION: With the study conditions, Gadomer-17 provided more prolonged differentiation of ischemic from remote myocardium than that with gadopentetate dimeglumine.

© RSNA, 2002

Index terms: Animals • Heart, perfusion, 511.12144 • Magnetic resonance (MR), contrast enhancement, 511.12143 • Magnetic resonance (MR), contrast media, 511.12143 • Myocardium, blood supply, 511.76, 511.771 • Myocardium, MR, 511.121412, 511.12143 • Myocardium, SPECT, 511.12162




This article has been cited by other articles:


Home page
 CirculationHome page
E. Spuentrup, K. M. Ruhl, R. M. Botnar, A. J. Wiethoff, A. Buhl, V. Jacques, M. T. Greenfield, G. A. Krombach, R. W. Gunther, M. G. Vangel, et al.
Molecular Magnetic Resonance Imaging of Myocardial Perfusion With EP-3600, a Collagen-Specific Contrast Agent: Initial Feasibility Study in a Swine Model
Circulation, April 7, 2009; 119(13): 1768 - 1775.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
G. A. Krombach, C. B. Higgins, M. Chujo, and M. Saeed
Gadomer-enhanced MR Imaging in the Detection of Microvascular Obstruction: Alleviation with Nicorandil Therapy
Radiology, August 1, 2005; 236(2): 510 - 518.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
C. U. Herborn, M. Schmidt, O. Bruder, E. Nagel, K. Shamsi, and J. Barkhausen
MR Coronary Angiography with SH L 643 A: Initial Experience in Patients with Coronary Artery Disease
Radiology, November 1, 2004; 233(2): 567 - 573.
[Abstract] [Full Text] [PDF]